Viracta Therapeutics Inc. (VIRX)
Market Closed
2 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 01
0
0%
After Hours
$
+0 +11.4519% 0. 01
388.7K Market Cap
- P/E Ratio
- Div Yield
379,813 Volume
- Eps
$ 0.01
Previous Close Want to track VIRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Viracta Therapeutics Inc. (VIRX) Statistics
Valuation metrics
Market Cap 388.7K
Enterprise value 13.63M
Trailing P/E (ttm) -0.01
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.02
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.29
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 0.01
52-Week high 0.19
Beta -
50-Day moving average -
200-Day moving average 0.01
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 57:200
Last split Date 25 Feb 2021
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.9%
Return on equity -1.29%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.32
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.39
Total debt (mrq) -
Total Debt/Equity (mrq) 1.4
Current ratio (mrq) 1.43%
Book value per share (mrq) 0.47
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
